UK markets closed

Taysha Gene Therapies, Inc. (TSHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4199-0.2001 (-7.64%)
As of 02:23PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-111,566
-111,566
-166,014
-174,523
-60,011
Depreciation & amortisation
1,371
1,371
1,172
492
9
Stock-based compensation
7,905
7,905
18,043
18,184
3,354
Change in working capital
-18,012
-18,012
18,518
28,667
-111
Accounts payable
-2,295
-2,295
-7,804
14,494
1,961
Other working capital
-80,387
-80,387
-113,259
-138,596
-39,811
Other non-cash items
9,268
9,268
3,471
10,138
26,030
Net cash provided by operating activities
-73,018
-73,018
-88,390
-117,042
-30,729
Cash flows from investing activities
Investments in property, plant and equipment
-7,369
-7,369
-24,869
-21,554
-9,082
Other investing activities
17
17
-61
-
-
Net cash used for investing activities
-7,352
-7,352
-24,930
-21,554
-9,082
Cash flows from financing activities
Debt repayment
-43,000
-43,000
-
0
-1,673
Common stock issued
140,790
140,790
53,244
0
165,854
Other financing activities
-1,015
-1,015
-1,400
-874
-
Net cash used provided by (used for) financing activities
136,393
136,393
52,097
39,083
291,064
Net change in cash
56,023
56,023
-61,223
-99,513
251,253
Cash at beginning of period
90,517
90,517
151,740
251,253
0
Cash at end of period
146,540
146,540
90,517
151,740
251,253
Free cash flow
Operating cash flow
-73,018
-73,018
-88,390
-117,042
-30,729
Capital expenditure
-7,369
-7,369
-24,869
-21,554
-9,082
Free cash flow
-80,387
-80,387
-113,259
-138,596
-39,811